Sterling is known as a global contract development and manufacturing organization, and their network spreads to a manufacturing site in Cramlington, United Kingdom, a recently GMP-licensed dedicated bioconjugation facility in Deeside, and a 111-acre site in Ringaskiddy, Ireland.

How mRNA will Shift Pharma Commercial Models with Jane True, Pfizer

By Chris Spivey

May 18th 2023

Jane True, vice-president of mRNA Commercial Strategy & Innovation and Global Pandemic Security Lead, Pfizer, shares her perspective on how mRNA will shift commercial models in the pharmaceutical industry.

Scaling Manufacturing Processes Using Single-Use Technologies

By Kai Lipinski

February 15th 2023

Although new single-use technologies offer the flexibility needed to overcome several challenges in ATMP production, there are many considerations and hurdles manufacturers must be aware of when scaling.

Gorodenkoff/Stock.adobe.com – Adherence to detail and thorough project management are required for successful tech transfer and scale up.

Scale-up and Tech Transfer: From Development Lab Studies to Commercial Production

By Doris Rottenbusch

November 3rd 2022

Adherence to detail and thorough project management are required for successful tech transfer and scale up.

<1 2 3 4

About Us

Advertise

Editorial Info

Editorial Advisory Board

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777